A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1745-6215
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial ; volume:21 ; number:1 ; day:3 ; month:6 ; year:2020 ; pages:1-3 ; date:12.2020
Trials ; 21, Heft 1 (3.6.2020), 1-3, 12.2020

Creator
Contributor
SpringerLink (Online service)

DOI
10.1186/s13063-020-04447-3
URN
urn:nbn:de:101:1-2020080500073921863891
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:57 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Other Objects (12)